Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Decent is a U.S. healthcare technology and health-plan company that built employer health plans around direct primary care rather than around traditional fee-for-service insurance design. The company focused on self-funded and level-funded plans for small and midsize employers, working with benefits brokers and primary care partners to provide lower-cost coverage with integrated care navigation and no-cost primary care access for members. Decent appears to have remained operational through its member plans, but in 2025 it announced a merger with Nice Healthcare and said it would operate under the Nice brand over time. The business is healthcare-related, but it is not a drug-development biotech or pharma company and does not appear to have a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Decent.